elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36612532-3C0B829D-7182-4CF7-8069-603B168282CF
Q36612532-3C0B829D-7182-4CF7-8069-603B168282CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36612532-3C0B829D-7182-4CF7-8069-603B168282CF
Novel therapies for Hodgkin Lymphoma.
P2860
Q36612532-3C0B829D-7182-4CF7-8069-603B168282CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36612532-3C0B829D-7182-4CF7-8069-603B168282CF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2c8290d991040c1df83afda76c8a1016583e74fc
P2860
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.